Fabriz Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 7 Months
- Last Filing with ROC 31 Mar 2024
About Fabriz Pharmaceutical
Fabriz Pharmaceutical Private Limited (FPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2023 (One year and seven months 19 days old ). Its registered office is in Dehradun, Uttarakhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Harishankar Mishra, Mohammad Akhtar, Sanjay Thakur, and One other member serve as directors at the Company.
Company Details
-
Location
Dehradun, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U46497UT2023PTC015857
-
Company No.
015857
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jun 2023
-
Date of AGM
19 Nov 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Fabriz Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Thakur
|
Managing Director | 27-Jun-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Harishankar Mishra
|
Director | 27-Jun-2023 | Current |
|
Mohammad Akhtar
|
Director | 27-Jun-2023 | Current |
|
Ajay Thakur
|
Director | 27-Jun-2023 | Current |
Financial Performance of Fabriz Pharmaceutical.
Enhance accessibility to Fabriz Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fabriz Pharmaceutical?
Unlock access to Fabriz Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Alliance Security & Allied Training Institute (I) LlpAjay Thakur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fabriz Pharmaceutical?
Unlock and access historical data on people associated with Fabriz Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fabriz Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fabriz Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.